Puma Biotechnology Stock Analysis

Puma Stock Analysis Notes

About 15.0% of the company outstanding shares are owned by corporate insiders. The book value of Puma Biotechnology was at this time reported as 1.12. The company has Price/Earnings To Growth (PEG) ratio of 0.03. Puma Biotechnology had not issued any dividends in recent years. Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company was founded in 2010 and is headquartered in Los Angeles, California. Puma Biotechnology operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 196 people. To find out more about Puma Biotechnology contact Alan Auerbach at 424-248-6500 or learn more at https://www.pumabiotechnology.com.

Puma Biotechnology Investment Alerts

Puma Biotechnology Upcoming and Recent Events

Puma Largest EPS Surprises

View All Earnings Estimates

Puma Biotechnology Thematic Classifications

Puma Stock Institutional Investors

Note, although Puma Biotechnology's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Puma Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 238.78 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Puma Biotechnology's market, we take the total number of its shares issued and multiply it by Puma Biotechnology's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Puma Profitablity

The company has Profit Margin (PM) of 0.09 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.21 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.21.

Management Efficiency

Puma Biotechnology has return on total asset (ROA) of 0.0919 % which means that it generated a profit of $0.0919 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.5754 %, meaning that it created $0.5754 on every $100 dollars invested by stockholders. Puma Biotechnology's management efficiency ratios could be used to measure how well Puma Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. The Puma Biotechnology's current Return On Tangible Assets is estimated to increase to 0.13. The Puma Biotechnology's current Return On Capital Employed is estimated to increase to 0.27. As of now, Puma Biotechnology's Return On Assets are increasing as compared to previous years.

Technical Drivers

As of the 2nd of May, Puma Biotechnology holds the Coefficient Of Variation of 4238.12, semi deviation of 4.31, and Risk Adjusted Performance of 0.024. Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Puma Biotechnology, as well as the relationship between them. Put it differently, you can use this information to find out if the company will indeed mirror its model of past market data, or the prices will eventually revert. We have analyzed and interpolated nineteen technical drivers for Puma Biotechnology, which can be compared to its competitors. Please check Puma Biotechnology standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if Puma Biotechnology is priced some-what accurately, providing market reflects its current price of 4.95 per share. Given that Puma Biotechnology has jensen alpha of 0.1135, we recommend you to check out Puma Biotechnology's recent market performance to make sure the company can sustain itself at a future point.

Puma Biotechnology Price Movement Analysis

Puma Biotechnology Insider Trading Activities

Puma Biotechnology Predictive Daily Indicators

Puma Biotechnology Corporate Filings

Puma Biotechnology Forecast Models

Puma Biotechnology's time-series forecasting models are one of many Puma Biotechnology's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Puma Biotechnology's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Puma Biotechnology prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Puma shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Puma Biotechnology. By using and applying Puma Stock analysis, traders can create a robust methodology for identifying Puma entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Puma analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Puma analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Puma Biotechnology stock analysis indicators help investors evaluate how Puma Biotechnology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Puma Biotechnology shares will generate the highest return on investment. By understating and applying Puma Biotechnology stock analysis, traders can identify Puma Biotechnology position entry and exit signals to maximize returns.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Puma Biotechnology. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. For more detail on how to invest in Puma Stock please use our How to Invest in Puma Biotechnology guide.You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

When running Puma Biotechnology's price analysis, check to measure Puma Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Puma Biotechnology is operating at the current time. Most of Puma Biotechnology's value examination focuses on studying past and present price action to predict the probability of Puma Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Puma Biotechnology's price. Additionally, you may evaluate how the addition of Puma Biotechnology to your portfolios can decrease your overall portfolio volatility.

Is Puma Biotechnology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Puma Biotechnology. If investors know Puma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Puma Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Puma Biotechnology is measured differently than its book value, which is the value of Puma that is recorded on the company's balance sheet. Investors also form their own opinion of Puma Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is Puma Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Puma Biotechnology's market value can be influenced by many factors that don't directly affect Puma Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Puma Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Puma Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Puma Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.